The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125554302 12555430 2 F 20160619 20160823 20160714 20160826 EXP FR-009507513-1607FRA005022 MERCK 81.35 YR M Y 0.00000 20160826 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125554302 12555430 1 PS EMEND APREPITANT 1 Oral UNK U 21549 CAPSULE
125554302 12555430 2 SS EMEND APREPITANT 1 UNK U 21549 CAPSULE
125554302 12555430 3 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 6 G, UNK U 0 6 G TABLET
125554302 12555430 4 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 500 MG, UNK U 0 500 MG TABLET
125554302 12555430 5 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 500 MG, UNK U 0 500 MG TABLET
125554302 12555430 6 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous (not otherwise specified) UNK U 0
125554302 12555430 7 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous (not otherwise specified) 2 MG, UNK U 0 2 MG
125554302 12555430 8 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous (not otherwise specified) 2 MG, UNK U 0 2 MG
125554302 12555430 9 SS PROCARBAZINE HYDROCHLORIDE PROCARBAZINE HYDROCHLORIDE 1 UNK N 0
125554302 12555430 10 SS ZOPHREN (ondansetron hydrochloride) ONDANSETRON HYDROCHLORIDE 1 UNK U 0
125554302 12555430 11 SS ZOPHREN (ondansetron hydrochloride) ONDANSETRON HYDROCHLORIDE 1 UNK U 0
125554302 12555430 12 C KEPPRA LEVETIRACETAM 1 U 0
125554302 12555430 13 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 U 0
125554302 12555430 14 C ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 U 0
125554302 12555430 15 C XATRAL ALFUZOSIN 1 U 0
125554302 12555430 16 C FLECAINE FLECAINIDE 1 U 0
125554302 12555430 17 C DITROPAN OXYBUTYNIN CHLORIDE 1 U 0
125554302 12555430 18 C DIFFU-K POTASSIUM CHLORIDE 1 U 0
125554302 12555430 19 C INNOHEP TINZAPARIN SODIUM 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125554302 12555430 1 Prophylaxis of nausea and vomiting
125554302 12555430 3 Central nervous system lymphoma
125554302 12555430 6 Central nervous system lymphoma
125554302 12555430 9 Central nervous system lymphoma
125554302 12555430 10 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
125554302 12555430 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125554302 12555430 Hepatocellular injury

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125554302 12555430 1 20160614 20160614 0
125554302 12555430 2 20160722 0
125554302 12555430 3 20160614 20160614 0
125554302 12555430 4 20160706 0
125554302 12555430 5 20160722 0
125554302 12555430 6 20160614 20160614 0
125554302 12555430 7 20160706 0
125554302 12555430 8 20160722 0
125554302 12555430 9 20160614 20160620 0
125554302 12555430 10 20160614 20160614 0
125554302 12555430 11 20160722 0